Stay updated with breaking news from Laboratory Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Paxlovid, the antiviral pill produced by Pfizer, has helped prevent many people infected with COVID-19 from being hospitalized or dying. But the U.S. government plans to stop footing the bill in 2023, and millions of people who are at the highest risk of severe illness and are least able to afford the drug – the uninsured and seniors – may have to pay the full price.
Millions of those least able to afford the drug and at the highest risk of severe illness may have to pay full price.
Within months, the government plans to stop footing the bill — and millions of the uninsured and seniors might have to pay full price. Experts say that means fewer people will get the potentially life-saving treatments.
WEDNESDAY, Dec. 7, 2022 (HealthDay News) -- The antiviral Paxlovid has kept people from getting really sick and dying from COVID-19 since it became available -- at no cost to
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.